Fluidigm Raises $34M in Private Financing Round | GenomeWeb

NEW YORK, Nov. 12 – Fluidigm of South San Francisco, Calif., said Monday it had raised $34 million in a round of private financing and has secured commitments for an additional $4 million.

The maker of microfluidics technologies for use on biochips said that it would use the money it raised in the series C financing round to further develop and market its microfluidic pump and valve technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.